DrugPatentWatch Database Preview
Investigational Drug Information for Gimeracil
Email this page to a colleague
What is the drug development status for Gimeracil?
Gimeracil is an investigational drug.
There have been 76 clinical trials for Gimeracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2013.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Fudan University, Taiho Oncology, Inc., and Yonsei University.
There are five hundred and fifty-five US patents protecting this investigational drug and five international patents.
Summary for Gimeracil
| US Patents | 555 |
| International Patents | 5,662 |
| US Patent Applications | 1,321 |
| WIPO Patent Applications | 982 |
| Japanese Patent Applications | 715 |
| Clinical Trial Progress | Phase 3 (2013-06-01) |
| Vendors | 99 |
Recent Clinical Trials for Gimeracil
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 2/Phase 3 |
| A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Canc | Ono Pharmaceutical Co. Ltd | Phase 3 |
| HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction | Xuefei.Wang | Phase 2 |
Clinical Trial Summary for Gimeracil
Top disease conditions for Gimeracil
Top clinical trial sponsors for Gimeracil
US Patents for Gimeracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Gimeracil | ⤷ Try it Free | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Try it Free |
| Gimeracil | ⤷ Try it Free | Aryl-cyanoguanidine compounds | Bayer Pharma Aktiengesellschaft (Berlin, DE) | ⤷ Try it Free |
| Gimeracil | ⤷ Try it Free | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI Corporation (Tokyo, JP) Ishikawa; Yoshihiro (Tokyo, JP) | ⤷ Try it Free |
| Gimeracil | ⤷ Try it Free | Multimodal silica-based nanoparticles | ⤷ Try it Free | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Gimeracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Gimeracil | Argentina | AR098961 | 2033-12-23 | ⤷ Try it Free |
| Gimeracil | Australia | AU2014372833 | 2033-12-23 | ⤷ Try it Free |
| Gimeracil | Canada | CA2934617 | 2033-12-23 | ⤷ Try it Free |
| Gimeracil | China | CN106163568 | 2033-12-23 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
